HP
ORKA

HealthInvest Partners’s Oruka Therapeutics ORKA Stock Holding History

HealthInvest Partners’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.22M Buy
+54,886
New +$3.66M 1.41% 30

Other funds holding ORKA

SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
BIG
Brookwood Investment Group Phoenix, Arizona $888M AUM 32.21% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM

HealthInvest Partners's ORKA Position: Q2 2026 in Review

HealthInvest Partners opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 54,886 shares worth $5.22M. The stake represents 1.41% of the portfolio and ranks #30 among its holdings.

25 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • HealthInvest Partners held 54,886 shares of Oruka Therapeutics worth $5.22M as of Q2 2026.
  • Oruka Therapeutics was a new HealthInvest Partners position in Q2 2026.
  • Oruka Therapeutics made up 1.41% of HealthInvest Partners's portfolio in Q2 2026, its #30 holding.
  • 25 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.